// App-Quantinova.ai

1476 : A therapeutic antibody that inhibits CD73 activity by dual mechanisms

Researchers

Presenter

  • Bryan C. Barnhart

Principal Investigators

  • Emanuela Sega

  • Aaron Yamniuk

  • Sandra Hatcher

  • Ming Lei

  • Haben Ghermazien

  • Anne Lewin

  • Xi-Tao Wang

  • Haichun Huang

  • Pingping Zhang

  • Alan Korman

Medical Centers

  • Bristol Myers Squibb, Redwood City, CA

  • Bristol-Myers Sqiubb, Princeton, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved